News
CIRTEC Medical Systems to support new UT Dallas-led Initiative to deliver biomedical technologies from laboratory bench to bedside more efficiently

Read More

Trial and error: pivotal trial design is key to medical-device success

Cirtec Medical Systems authors article on clinical trial design in The Engineers Journal. Read More

Medical Device Maker Moving to Enfield

Cirtec Medical Systems, a medical device manufacturer, will begin moving into a new plant in Enfield by midyear, the company has announced.
Read More

CIRTEC Medical Systems Expands Capacity with New Advanced Manufacturing Facility

East Longmeadow, Mass. (PRWEB) April 28, 2015: CIRTEC Medical Systems, a leading provider of outsourced medical device manufacturing services for complex Class III implantable devices and minimally invasive devices, today announced plans to develop a new 35,000 sq. ft. advanced manufacturing facility in Enfield, Conn.
Read More…

Brian Highley Appointed CEO of CIRTEC Medical Systems

East Longmeadow, MA, September 16, 2014 – CIRTEC Medical Systems’ Board of Directors has announced the appointment of Brian Highley as CEO of CIRTEC.
Read More…More on Brian Highley appointment

For these medical devices, the future is now

Medical Design, May 20, 1014–Bionic limbs, ingestible sensors, neurostimulation, and shrinking implantable devices are opening new potentials in medical technology. They also bring many challenges that will need to be met in the future.

Read more…For these medical devices, the future is now

FDA Inspection of CIRTEC Medical Device Manufacturing Facility Finds No Corrective Actions Required

East Longmeadow, Mass. November 1, 2013. CIRTEC Medical Systems, the leading contract manufacturer for implantable, minimally invasive and electronic systems and instrumentation for the medical device industry, announced today the CIRTEC East Longmeadow facility hosted a 5-day FDA inspection starting Thursday, October 23 and concluding Tuesday, October 30. The inspection was focused on one particular product currently being submitted for FDA review and clearance, with a general assessment of our entire Quality System included in the scope. The result of the inspection was that no findings requiring a Form 483 were uncovered. All quality systems were found to be compliant and effective in order to ensure the safety and efficacy of the product produced at CIRTEC.

Read more…FDA Inspection Finds No Corrective Actions Required